Related Experiment Videos

Penetration of ceftazidime into intracranial abscess

H T Green1, M A O'Donoghue, M D Shaw

  • 1Department of Microbiology, Walton Hospital, Liverpool, UK.

Insights

Ceftazidime penetrates intracranial abscesses, with concentrations ranging from 2.7 to 27.0 mg/l detected in pus. This study investigates its potential role in treating brain abscesses originating from ear infections.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Neurosurgery

Background:

  • Intracranial abscesses pose significant treatment challenges.
  • Understanding antibiotic penetration is crucial for effective therapy.
  • Ceftazidime is a third-generation cephalosporin with broad-spectrum activity.

Purpose of the Study:

  • To investigate the penetration of ceftazidime into intracranial abscesses.
  • To determine ceftazidime concentrations in abscess pus.
  • To evaluate the potential role of ceftazidime in treating intracranial abscesses of otogenic origin.

Main Methods:

  • Nine patients with intracranial abscesses received intravenous ceftazidime.
  • Antibiotic concentrations in pus were measured using microbiological agar diffusion assay (12 samples) and high-performance liquid chromatography (8 samples).
  • Measurements were taken at various times post-administration.

Main Results:

  • Ceftazidime concentrations in intracranial abscess pus ranged from 2.7 to 27.0 mg/l.
  • The data indicate measurable penetration of ceftazidime into the abscess cavity.

Conclusions:

  • Ceftazidime demonstrates penetration into intracranial abscesses.
  • Further evaluation is warranted for its therapeutic role in otogenic intracranial abscesses.
  • These findings contribute to optimizing antibiotic strategies for brain infections.

Related Concept Videos